Table 1. Adjuvant chemotherapy regimen in RIPK3 protein high- and low- expression groups.
Regimen | RIPK3 | P value | |
---|---|---|---|
High (n=24) | Low (n=26) | ||
Paclitaxel/CDDP | 20 | 22 | 0.845 |
Vinorelbine/CDDP | 4 | 4 |
CDDP, cis-diamminedichloroplatinum (cisplatin).
Regimen | RIPK3 | P value | |
---|---|---|---|
High (n=24) | Low (n=26) | ||
Paclitaxel/CDDP | 20 | 22 | 0.845 |
Vinorelbine/CDDP | 4 | 4 |
CDDP, cis-diamminedichloroplatinum (cisplatin).